$211.25
Price
$29.5B
Market Cap
—
P/E Ratio
-106.3
Forward P/E
$-2.28
EPS (TTM)
—
Dividend Yield
$1.0B
Cash
$187M
Total Debt
139M
Shares Out
$125.38
$256.36
52-Week Range
Institutional Ownership of NATERA INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for NATERA INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +4.6% | 11.9K | $2M | $161.57 | |
| SELL | -9.2% | 2.9K | $470998 | $161.57 | |
| 2025-Q2 | |||||
| SELL | -0.2% | 11.4K | $2M | $154.53 | |
| BUY | NEW | 3.2K | $544494 | $154.53 | |
| 2025-Q1 | |||||
| SELL | -0.2% | 11.4K | $2M | $165.76 | |
| 2024-Q4 | |||||
| SELL | -28.9% | 11.4K | $2M | $146.06 | |
| 2024-Q3 | |||||
| BUY | +0.6% | 16.1K | $2M | $114.57 | |
| 2024-Q2 | |||||
| SELL | -7.8% | 16.0K | $2M | $105.52 | |
| 2024-Q1 | |||||
| SELL | -20.3% | 17.3K | $2M | $69.92 | |
| 2023-Q4 | |||||
| BUY | +4.8% | 21.8K | $1M | $52.12 | |
| 2023-Q3 | |||||
| BUY | +3.7% | 20.8K | $919294 | $51.02 | |
| 2023-Q2 | |||||
| BUY | +0.8% | 20.0K | $974465 | $51.00 | |
| 2023-Q1 | |||||
| BUY | +1.1% | 19.9K | $1M | $46.55 | |
| 2022-Q4 | |||||
| BUY | +17.3% | 19.6K | $789059 | $41.25 | |
| 2022-Q3 | |||||
| BUY | NEW | 16.7K | $734000 | $48.51 | |
Insider Trading for NATERA INC
6 Months Insider Sentiment
Buy $0
Sell $92.4M
0
Buys
121
Sells
-92.4M
Net
13
Grants
Largest
$31.3M
Chapman
$18.0M
Chapman
$4.5M
Botha
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 14, 2026 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | GRANT | 59.6K | — | — |
| Jan 14, 2026 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | GRANT | 37.2K | — | — |
| Jan 14, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | GRANT | 44.7K | — | — |
| Jan 14, 2026 | Steven Leonard Chapman | CEO AND PRESIDENT | GRANT | 152.7K | — | — |
| Jan 14, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | GRANT | 44.7K | — | — |
| Jan 14, 2026 | Jonathan Sheena | Director | GRANT | 7.5K | — | — |
| Jan 05, 2026 | Jonathan Sheena | Director | EXERCISE | 39.6K | $9.59 | $380K |
| Jan 02, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.7K | $229.43 | $381K |
| Jan 02, 2026 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 1.6K | $229.67 | $375K |
| Jan 02, 2026 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 2.2K | $228.64 | $506K |
| Jan 02, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.3K | $228.33 | $295K |
| Dec 19, 2025 | Jonathan Sheena | Director | SELL | 200 | $224.89 | $45K |
| Dec 19, 2025 | Jonathan Sheena | Director | SELL | 550 | $226.36 | $124K |
| Dec 17, 2025 | Jonathan Sheena | Director | SELL | 1.6K | $226.54 | $361K |
| Dec 17, 2025 | Jonathan Sheena | Director | SELL | 1.3K | $227.44 | $307K |
| Dec 17, 2025 | Jonathan Sheena | Director | SELL | 130 | $228.28 | $30K |
| Dec 15, 2025 | Jonathan Sheena | Director | GRANT | 1.1K | — | — |
| Dec 15, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | GRANT | 115 | — | — |
| Dec 12, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | EXERCISE | 8.9K | $9.59 | $85K |
| Dec 12, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 4.7K | $230.76 | $1.1M |
| Dec 12, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | GRANT | 180 | — | — |
| Dec 12, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | EXERCISE | 13.5K | $9.59 | $129K |
| Dec 09, 2025 | Jonathan Sheena | Director | EXERCISE | 4.4K | $9.29 | $41K |
| Dec 05, 2025 | Rowan E Chapman | Director | SELL | 366 | $243.39 | $89K |
| Dec 05, 2025 | Rowan E Chapman | Director | EXERCISE | 4.0K | $32.15 | $129K |
| Dec 05, 2025 | Rowan E Chapman | Director | SELL | 4.0K | $243.08 | $972K |
| Dec 04, 2025 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | EXERCISE | 6.9K | $19.68 | $136K |
| Dec 01, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 956 | $239.44 | $229K |
| Dec 01, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 1.4K | $237.05 | $330K |
| Dec 01, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 2.0K | $238.13 | $488K |
| Dec 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 250 | $237.77 | $59K |
| Dec 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 474 | $239.53 | $114K |
| Dec 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 749 | $237.23 | $178K |
| Dec 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.5K | $238.24 | $364K |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 10.0K | $234.55 | $2.3M |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 500 | $239.11 | $120K |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 900 | $231.23 | $208K |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 1.0K | $230.03 | $230K |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 2.0K | $228.97 | $458K |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 3.6K | $232.75 | $839K |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 6.2K | $236.54 | $1.5M |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 7.0K | $233.66 | $1.6M |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 9.6K | $235.65 | $2.3M |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 15.3K | $237.69 | $3.6M |
| Nov 24, 2025 | Roelof Botha | Director | SELL | 18.8K | $238.57 | $4.5M |
| Nov 21, 2025 | Jonathan Sheena | Director | SELL | 2.0K | $230.01 | $460K |
| Nov 20, 2025 | Jonathan Sheena | Director | SELL | 10.0K | $225.08 | $2.3M |
| Nov 20, 2025 | Roy D. Baynes | Director | SELL | 1.9K | $224.89 | $424K |
| Nov 20, 2025 | Roy D. Baynes | Director | SELL | 1.9K | $223.90 | $425K |
| Nov 20, 2025 | Roy D. Baynes | Director | EXERCISE | 600 | $40.93 | $25K |
| Nov 20, 2025 | Roy D. Baynes | Director | SELL | 1.8K | $222.90 | $401K |
| Nov 20, 2025 | Roy D. Baynes | Director | EXERCISE | 7.1K | $41.19 | $291K |
| Nov 20, 2025 | Roy D. Baynes | Director | SELL | 900 | $221.81 | $200K |
| Nov 20, 2025 | Roy D. Baynes | Director | SELL | 1.2K | $220.14 | $261K |
| Nov 19, 2025 | Roy D. Baynes | Director | SELL | 1.2K | $213.47 | $267K |
| Nov 19, 2025 | Roy D. Baynes | Director | SELL | 2.1K | $216.07 | $461K |
| Nov 19, 2025 | Roy D. Baynes | Director | SELL | 1.7K | $214.79 | $371K |
| Nov 19, 2025 | Roy D. Baynes | Director | EXERCISE | 5.1K | $40.93 | $209K |
| Nov 11, 2025 | Jonathan Sheena | Director | SELL | 382 | $207.95 | $79K |
| Nov 11, 2025 | Jonathan Sheena | Director | SELL | 190 | $206.86 | $39K |
| Nov 11, 2025 | Jonathan Sheena | Director | SELL | 170 | $209.28 | $36K |
| Nov 11, 2025 | Jonathan Sheena | Director | SELL | 163 | $209.28 | $34K |
| Nov 11, 2025 | Jonathan Sheena | Director | SELL | 205 | $206.86 | $42K |
| Nov 11, 2025 | Jonathan Sheena | Director | SELL | 390 | $207.94 | $81K |
| Nov 07, 2025 | Jonathan Sheena | Director | SELL | 300 | $193.59 | $58K |
| Nov 07, 2025 | Jonathan Sheena | Director | SELL | 100 | $196.78 | $20K |
| Nov 07, 2025 | Jonathan Sheena | Director | SELL | 1.5K | $190.33 | $282K |
| Nov 07, 2025 | Jonathan Sheena | Director | SELL | 600 | $196.06 | $118K |
| Nov 07, 2025 | Jonathan Sheena | Director | SELL | 90 | $191.04 | $17K |
| Nov 07, 2025 | Jonathan Sheena | Director | SELL | 400 | $192.64 | $77K |
| Nov 04, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 5.7K | $201.18 | $1.1M |
| Nov 04, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 17.2K | $200.29 | $3.4M |
| Nov 03, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | EXERCISE | 3.6K | $20.27 | $73K |
| Nov 03, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 17.1K | $200.00 | $3.4M |
| Nov 03, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | EXERCISE | 150.0K | $119.75 | $18.0M |
| Nov 03, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 2.2K | $198.03 | $439K |
| Nov 03, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 156.6K | $200.00 | $31.3M |
| Nov 03, 2025 | Gail Boxer Marcus | Director | SELL | 122 | $198.71 | $24K |
| Nov 03, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | EXERCISE | 2.1K | $13.01 | $27K |
| Nov 03, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.4K | $198.03 | $287K |
| Nov 03, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 100 | $199.74 | $20K |
| Nov 03, 2025 | Jonathan Sheena | Director | SELL | 2.0K | $200.14 | $400K |
| Nov 03, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 1.9K | $198.96 | $381K |
| Oct 31, 2025 | Brinkley Ruth Williams | Director | GRANT | 97 | — | — |
| Oct 31, 2025 | Monica Bertagnolli | Director | GRANT | 93 | — | — |
| Oct 31, 2025 | Roelof Botha | Director | GRANT | 149 | — | — |
| Oct 31, 2025 | Rowan E Chapman | Director | GRANT | 128 | — | — |
| Oct 29, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 500 | $192.12 | $96K |
| Oct 29, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 300 | $188.37 | $57K |
| Oct 29, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 400 | $189.91 | $76K |
| Oct 29, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 667 | $190.99 | $127K |
| Oct 28, 2025 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | SELL | 1.1K | $191.46 | $203K |
| Oct 28, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 3.7K | $191.46 | $705K |
| Oct 28, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 1.2K | $191.46 | $237K |
| Oct 28, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 574 | $189.90 | $109K |
| Oct 28, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 404 | $191.51 | $77K |
| Oct 28, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 200 | $192.19 | $38K |
| Oct 28, 2025 | Jonathan Sheena | Director | SELL | 191 | $191.46 | $37K |
| Oct 28, 2025 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | SELL | 928 | $191.46 | $178K |
| Oct 27, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 2.3K | $192.32 | $449K |
| Oct 27, 2025 | Jonathan Sheena | Director | SELL | 288 | $192.32 | $55K |
| Oct 27, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 781 | $192.32 | $150K |
| Oct 27, 2025 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | SELL | 935 | $192.32 | $180K |
| Oct 27, 2025 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | SELL | 781 | $192.32 | $150K |
| Oct 24, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 755 | $196.77 | $149K |
| Oct 23, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 495 | $187.16 | $93K |
| Oct 22, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 920 | $186.68 | $172K |
| Oct 21, 2025 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | SELL | 602 | $187.95 | $113K |
| Oct 21, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 1.6K | $187.95 | $301K |
| Oct 21, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 292 | $187.95 | $55K |
| Oct 21, 2025 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | SELL | 464 | $187.95 | $87K |
| Oct 21, 2025 | Jonathan Sheena | Director | SELL | 93 | $187.95 | $17K |
| Oct 21, 2025 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | SELL | 339 | $187.95 | $64K |
| Oct 20, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 10.0K | $190.00 | $1.9M |
| Oct 17, 2025 | Jonathan Sheena | Director | SELL | 475 | $178.66 | $85K |
| Oct 17, 2025 | Jonathan Sheena | Director | SELL | 275 | $179.35 | $49K |
| Oct 17, 2025 | Jonathan Sheena | Director | SELL | 413 | $178.58 | $74K |
| Oct 17, 2025 | Jonathan Sheena | Director | SELL | 337 | $179.29 | $60K |
| Oct 15, 2025 | Jonathan Sheena | Director | SELL | 153 | $172.99 | $26K |
| Oct 15, 2025 | Jonathan Sheena | Director | SELL | 1.5K | $175.11 | $264K |
| Oct 15, 2025 | Jonathan Sheena | Director | SELL | 423 | $176.63 | $75K |
| Oct 15, 2025 | Jonathan Sheena | Director | SELL | 988 | $175.90 | $174K |
| Oct 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 404 | $158.96 | $64K |
| Oct 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.8K | $159.91 | $290K |
| Oct 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 780 | $160.70 | $125K |
| Sep 30, 2025 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | SELL | 1.4K | $162.05 | $221K |
| Sep 19, 2025 | Jonathan Sheena | Director | SELL | 3.6K | $179.09 | $645K |
| Sep 19, 2025 | Jonathan Sheena | Director | SELL | 3.4K | $179.08 | $617K |
| Sep 19, 2025 | Jonathan Sheena | Director | SELL | 1.5K | $180.06 | $273K |
| Sep 19, 2025 | Jonathan Sheena | Director | SELL | 1.4K | $179.88 | $248K |
| Sep 19, 2025 | Jonathan Sheena | Director | SELL | 676 | $180.68 | $122K |
| Sep 19, 2025 | Jonathan Sheena | Director | SELL | 380 | $180.68 | $69K |
| Sep 19, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 24.3K | $180.54 | $4.4M |
| Sep 19, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 1.2K | $181.28 | $215K |
| Sep 18, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 10.0K | $180.00 | $1.8M |
| Sep 18, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 14.5K | $180.13 | $2.6M |
| Sep 17, 2025 | Jonathan Sheena | Director | SELL | 256 | $176.61 | $45K |
| Sep 17, 2025 | Jonathan Sheena | Director | SELL | 2.8K | $175.88 | $495K |
| Sep 12, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 4.5K | $170.31 | $766K |
| Sep 12, 2025 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | SELL | 500 | $172.64 | $86K |
| Sep 02, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.2K | $167.71 | $203K |
| Sep 02, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 1.7K | $165.44 | $281K |
| Sep 02, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 1.5K | $166.29 | $245K |
| Sep 02, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.3K | $165.69 | $214K |
| Sep 02, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 1.9K | $167.69 | $320K |
| Sep 02, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 500 | $166.39 | $83K |